IRIS Accounts Production v23.1.0.753 10637955 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure106379552022-03-31106379552023-03-31106379552022-04-012023-03-31106379552021-03-31106379552021-04-012022-03-31106379552022-03-3110637955ns16:EnglandWales2022-04-012023-03-3110637955ns15:PoundSterling2022-04-012023-03-3110637955ns11:Director12022-04-012023-03-3110637955ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3110637955ns11:SmallEntities2022-04-012023-03-3110637955ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3110637955ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110637955ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3110637955ns11:FullAccounts2022-04-012023-03-3110637955ns11:Director22022-04-012023-03-3110637955ns11:RegisteredOffice2022-04-012023-03-3110637955ns6:CurrentFinancialInstruments2023-03-3110637955ns6:CurrentFinancialInstruments2022-03-3110637955ns6:Non-currentFinancialInstruments2023-03-3110637955ns6:Non-currentFinancialInstruments2022-03-3110637955ns6:ShareCapital2023-03-3110637955ns6:ShareCapital2022-03-3110637955ns6:RetainedEarningsAccumulatedLosses2023-03-3110637955ns6:RetainedEarningsAccumulatedLosses2022-03-3110637955ns6:PlantMachinery2022-04-012023-03-3110637955ns6:PlantMachinery2022-03-3110637955ns6:PlantMachinery2023-03-3110637955ns6:PlantMachinery2022-03-3110637955ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3110637955ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-31
REGISTERED NUMBER: 10637955 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

AVENUEBIO CONSULTING LTD

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


AVENUEBIO CONSULTING LTD

COMPANY INFORMATION
for the Year Ended 31 March 2023







DIRECTORS: M Craig
Mrs J J Craig





REGISTERED OFFICE: Highlands
Boundary Road
Dockenfield
Surrey
GU10 4EU





REGISTERED NUMBER: 10637955 (England and Wales)






AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

BALANCE SHEET
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 59,961 63,269

CURRENT ASSETS
Debtors 5 730,835 282,865
Investments 6 - 63,945
Cash at bank and in hand 462,911 622,332
1,193,746 969,142
CREDITORS
Amounts falling due within one year 7 556,396 344,412
NET CURRENT ASSETS 637,350 624,730
TOTAL ASSETS LESS CURRENT
LIABILITIES

697,311

687,999

CREDITORS
Amounts falling due after more than one
year

8

(15,312

)

(22,104

)

PROVISIONS FOR LIABILITIES (15,000 ) (12,021 )
NET ASSETS 666,999 653,874

CAPITAL AND RESERVES
Called up share capital 3 3
Retained earnings 666,996 653,871
SHAREHOLDERS' FUNDS 666,999 653,874

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

BALANCE SHEET - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 October 2023 and were signed on its behalf by:





M Craig - Director


AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

AvenueBio Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about AvenueBio Consulting Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 25% on cost

Fixed assets are stated at their cost prices, less accumulated depreciation and amounts recognised in respect of impairment.

Investments
Investments relate to an investment in an unlisted entity which is stated at cost less impairment. At each balance sheet date, the investment is assessed for indicators of impairment and where there are indicators of impairment, recoverable amount is assessed. If recoverable amount is less than carrying amount, the investment is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment.
Debtors and creditors that fall due within one year are recorded in the financial statements at transaction price and then subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded within profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt. Debtors do not carry interest and are stated at their nominal value. Trade creditors are not interest-bearing and are stated at their nominal value.
Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognized in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2022 - 9 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 86,602
Additions 14,820
At 31 March 2023 101,422
DEPRECIATION
At 1 April 2022 23,333
Charge for year 18,128
At 31 March 2023 41,461
NET BOOK VALUE
At 31 March 2023 59,961
At 31 March 2022 63,269

AVENUEBIO CONSULTING LTD (REGISTERED NUMBER: 10637955)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 319,717 242,650
Other debtors 411,118 40,215
730,835 282,865

6. CURRENT ASSET INVESTMENTS
2023 2022
£    £   
Unlisted investments - 63,945

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 6,792 6,625
Trade creditors 83,593 13,169
Taxation and social security 361,316 319,748
Other creditors 104,695 4,870
556,396 344,412

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Bank loans 15,312 22,104

9. OTHER FINANCIAL COMMITMENTS

Total financial commitments, guarantees and contingencies which are not included in the balance sheet amount to £33,633.63 (2022: £45,447.74) and are in relation to commitments under operating leases.

10. THE ENTITY’S ABILITY TO CONTINUE AS A GOING CONCERN - COVID-19

Management has considered the consequences of COVID-19 and other events and conditions. The impact of COVID-19 on future performance and therefore on the measurement of some assets and liabilities is unknown and might require future disclosure in the financial statements. At present the management has determined that the impact of COVID-19 does not create a material uncertainty that casts significant doubt upon the entity's ability to continue as a going concern.